Suddenly it seems there are consultations all over the place that are important to the digital health world. If you can spare some time, you will be doing society a great turn by responding to as many as possible. They include:
The Accelerated Access Review (disclosure, which is editor is very involved with) is holding a consultation on pricing & reimbursement schemes. This is important because in the area of digital health (one of three areas covered by the AAR, the other two being medicines and medtech), selling at scale almost always involves a competitive tender (either at the time or previously in establishing framework contracts, or sometimes at both stages). We therefore have much to learn from the pharma sector in particular who have established a wide range of price-setting, and thus tender-avoiding, mechanisms. We are very keen for the digital health and medical technology voices to be heard.
Deadline for submissions is Friday 20th November.
Next we have an EC consultation with a characteristically long-winded title Public consultation on the preliminary opinion on ‘Disruptive Innovation. Considerations for health and health care in Europe’. For this, the EC is partnering with an organisation previously unknown to this editor: the Expert Panel on Effective Ways of Investing in Health (EXPH). Having learned about disruptive innovation at the feet of the man himself, Clayton Christensen, this editor gets just a little uncomfortable when experts seek to impose order on the process (especially ‘taxonomies’), as by definition it is chaotic and opportunistic. However the four areas that the survey seeks views on are:
1. New models of person-centred community-based health delivery that allow a decentralisation from traditional health care venues like hospitals to integrated care models (e.g. transfer of records to patients);
2. New technologies that allow early diagnostics, personalised medicine, health promotion, community-based therapy and care and the empowerment of patients/citizens, as well as potential curative technologies (e.g. regenerative medicine, immunotherapy for cancer);
3. Person-oriented approaches for the treatment of patients with multiple chronic diseases, situations of frailty and/or of loss of functionalities in a multi-cultural context;
4. Education of the health workforce and transfer of skills and tasks from highly trained, high cost personnel to personnel that have less specialised trained and are more affordable; (e.g. from specialists to generalists, from generalists to nurses, from nurses to health care assistants and to other care providers such as pharmacists, and ultimately to citizens themselves.)
The preliminary opinion is just 95 pages long, and here. The consultation closes on 16th December.
Closer to home and potentially of more immediate significance is the consultation on the draft EU Code of Conduct on data privacy for medical apps which is now being opened up for general consultation prior to a meeting in Brussels of the group producing the Code (of which this editor is a member) on December 7th. Please send your comments directly to charles.lowe@DHACA.org.uk and I will pass them on.
Finally, London’s Southbank University is planning to establish a set of qualifications for digital health-related topics and is keen to understand the likely willingness to pay for them. They are currently in discussion with the Royal Society of Medicine regarding use of educational material. They have produced this short survey which they would appreciate as many TTA readers as possible completing.
Hat tip to Dee O’Sullivan for alerting me to the disruptive innovation consultation.